FDA

News

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

Vinay Prasad abruptly departs from the FDA

The disruption at the FDA continues with the departure of CBER director Vinay Prasad, less than three months after taking on the role.

News

FDA gives the go-ahead to restart Elevidys shipments

Sarepta has restarted distribution of its Duchenne muscular dystrophy gene therapy Elevidys, but only for patients who can walk.

R&D

magnifying glass over a figure in red amid many in black

Novel study designs for rare diseases

Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs.

News

Sarepta backs down and pauses Elevidys shipments

The FDA seems to have won its staring contest with Sarepta over shipments of Elevidys, as the company blinks and agrees to a pause from today.

News

FDA names a new CDER director, choosing a biotech vet

The FDA has rounded out its senior leadership by naming biopharma industry executive George Tidmarsh to the role of CDER director.

Tidmarsh to stand in for Prasad's role at CBER

Vinay Prasad abruptly departs from the FDA

FDA gives the go-ahead to restart Elevidys shipments

Novel study designs for rare diseases

Sarepta backs down and pauses Elevidys shipments

FDA names a new CDER director, choosing a biotech vet

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

FDA

Editor's Picks